NYSE:LLYPharmaceuticals
Eli Lilly (LLY) Wins Canada Backing For Ebglyss As Oncology Progress Builds
Eli Lilly's eczema drug Ebglyss received a positive recommendation from Canada's Drug Agency, supporting future public reimbursement.
The company agreed a new distribution arrangement for cancer drug Verzenios in mainland China.
The European Medicines Agency issued a positive opinion for Jaypirca in chronic lymphocytic leukemia, moving it closer to wider use in Europe.
Eli Lilly, ticker NYSE:LLY, is drawing fresh attention for developments outside its high profile obesity and diabetes...